Business

The FTC Is Suing Hims and Hers for Sharing Patients’ Health Data With Facebook and Snapchat

By Mike Harper · July 30, 2026

You told a health app about your medical condition. That information went to Facebook.

The Federal Trade Commission sued telehealth company Hims & Hers on Wednesday, alleging it shared customers’ sensitive health information — including data about conditions like erectile dysfunction, hair loss, and mental health — with Meta and Snap through tracking technologies embedded on its website, despite telling users their data was private.

The lawsuit, filed in U.S. District Court for the Northern District of California and joined by the state of Utah and Los Angeles County, goes beyond the data-sharing allegations. The FTC also accuses the company of a billing practice that most customers don’t realize until they check their credit card statement: charging for prescriptions almost immediately after a patient fills out an intake form, before they’ve spoken with a healthcare provider.

Most customers never receive a consultation with a medical professional, according to the complaint. They fill out a form, get billed, and receive a prescription in the mail. The FTC says the company failed to clearly disclose this process.

The third allegation is familiar to anyone who’s tried to cancel a subscription service: the FTC says Hims & Hers deliberately made cancellation difficult, trapping customers in recurring charges they didn’t want.

“Consumers unknowingly locked into recurring subscriptions and the disclosure to third parties of consumers’ most private health information without their consent.” Christopher Mufarrige, Director of the FTC’s Bureau of Consumer Protection, said.

Hims & Hers denied the allegations in a statement posted on X, calling the lawsuit an effort to “generate headlines at our expense” and saying it “disregards substantial evidence” provided during the FTC’s nearly three-year investigation. The company said it intends to fight the case. Its stock fell roughly 12% on the news.

The company is one of the largest telehealth platforms in the U.S., offering prescriptions for weight loss, hair loss, erectile dysfunction, and mental health medications shipped directly to customers. It reported $608 million in revenue in the first quarter of 2026 — even as it swung to a $92 million net loss.

The FTC opened its inquiry in October 2023, according to CNBC. By April 2026, the agency communicated its findings to the company and settlement talks began, but the parties could not reach an agreement.

The case adds to a growing list of FTC actions targeting companies that promised to keep health data private and didn’t. For anyone who filled out an intake form on the Hims & Hers website, the question isn’t abstract: information about the most personal medical conditions you disclosed to what you thought was a confidential health platform may have been shared with advertising companies so they could sell you more products.